| Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease L Terrin, E Rampazzo, S Pucciarelli, M Agostini, R Bertorelle, G Esposito, ... Clinical Cancer Research 14 (22), 7444-7451, 2008 | 105 | 2008 |
| Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy M Agostini, S Pucciarelli, MV Enzo, P Del Bianco, M Briarava, C Bedin, ... Annals of surgical oncology 18 (9), 2461-2468, 2011 | 97 | 2011 |
| Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy M Agostini, S Pucciarelli, MV Enzo, P Del Bianco, M Briarava, C Bedin, ... Annals of surgical oncology 18 (9), 2461-2468, 2011 | 97 | 2011 |
| A specific mutational signature associated with DNA 8-oxoguanine persistence in MUTYH-defective colorectal cancer A Viel, A Bruselles, E Meccia, M Fornasarig, M Quaia, V Canzonieri, ... EBioMedicine 20, 39-49, 2017 | 86 | 2017 |
| Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy E Cecchin, M Agostini, S Pucciarelli, A De Paoli, V Canzonieri, R Sigon, ... The pharmacogenomics journal 11 (3), 214-226, 2011 | 74 | 2011 |
| Two PMS2 mutations in a Turcot syndrome family with small bowel cancers. VA Agostini M, Tibiletti Mg, Lucci-Cordisco E, Chiaravalli A, Morreau H ... Am J Gastroenterol 100 (8), 1886-91, 2005 | 71 | 2005 |
| A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation S Terrazzino, M Agostini, S Pucciarelli, LM Pasetto, ML Friso, A Ambrosi, ... Pharmacogenetics and genomics 16 (11), 817-824, 2006 | 69 | 2006 |
| Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients M Agostini, MV Enzo, C Bedin, V Belardinelli, E Goldin, P Del Bianco, ... Cancer Biomarkers 11 (2-3), 89-98, 2012 | 65 | 2012 |
| Extracellular matrix and colorectal cancer: how surrounding microenvironment affects cancer cell behavior? S Crotti, M Piccoli, F Rizzolio, A Giordano, D Nitti, M Agostini Journal of cellular physiology 232 (5), 967-975, 2017 | 63 | 2017 |
| Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer R Bertorelle, M Briarava, E Rampazzo, L Biasini, M Agostini, I Maretto, ... British journal of cancer 108 (2), 278-284, 2013 | 62 | 2013 |
| Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients C Bedin, MV Enzo, P Del Bianco, S Pucciarelli, D Nitti, M Agostini International journal of cancer 140 (8), 1888-1898, 2017 | 61 | 2017 |
| Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer J Chen, I Guccini, D Di Mitri, D Brina, A Revandkar, M Sarti, E Pasquini, ... Nature genetics 50 (2), 219-228, 2018 | 57 | 2018 |
| Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant … S Pucciarelli, E Rampazzo, M Briarava, I Maretto, M Agostini, M Digito, ... Annals of Surgical Oncology 19 (9), 3089-3096, 2012 | 56 | 2012 |
| Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer E Mammano, C Belluco, M Sciro, R Mencarelli, M Agostini, M Michelotto, ... Anticancer research 26 (5A), 3547-3550, 2006 | 54 | 2006 |
| Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression L Perilli, C Vicentini, M Agostini, S Pizzini, M Pizzi, E D'Angelo, ... Oncotarget 5 (16), 6611, 2014 | 53 | 2014 |
| Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAFV600E: A non-invasive tool panel for early detection of thyroid cancer M Zane, M Agostini, MV Enzo, EC Ide, P Del Bianco, F Torresan, ... Biomedicine & Pharmacotherapy 67 (8), 723-730, 2013 | 53 | 2013 |
| miRNAs in colon and rectal cancer: A consensus for their true clinical value M Agostini, S Pucciarelli, F Calore, C Bedin, MV Enzo, D Nitti Clinica Chimica Acta 411 (17-18), 1181-1186, 2010 | 52 | 2010 |
| NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells A Pastò, V Serafin, G Pilotto, C Lago, C Bellio, L Trusolino, A Bertotti, ... Cancer research 74 (7), 2106-2118, 2014 | 50 | 2014 |
| Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma E D'Angelo, M Fassan, I Maretto, S Pucciarelli, C Zanon, M Digito, ... Oncotarget 7 (19), 28647, 2016 | 45 | 2016 |
| Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion C Pastrello, S Baglioni, MG Tibiletti, L Papi, M Fornasarig, A Morabito, ... European journal of human genetics 14 (1), 63-68, 2006 | 43 | 2006 |
Salvatore PucciarelliVerified email at unipd.it
